Reitan Colleen F sold ALNY
September 9, 2025 · Form 4 insider transaction
Reitan Colleen F sold 25 shares of Alnylam Pharmaceuticals, Inc. at $480.98 per share, a transaction worth $12.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
25
Price
$480.98
Total value
$12.0K
InsiderReitan Colleen F
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 9, 2025
Filing dateSeptember 11, 2025
Shares owned after775
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 10, 2025.